Covered recipient · General Payments record
KENZIE NICOLE MURPHY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$2,935.48
- Reported across 173 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $674.38 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.61 | 12 |
| PFIZER INC. | $126.67 | 4 |
| Novo Nordisk AS | $107.11 | 6 |
| Lilly USA, LLC | $50.18 | 3 |
| Lundbeck LLC | $47.55 | 2 |
| Phathom Pharmaceuticals, Inc. | $39.78 | 2 |
| Astellas Pharma US Inc | $35.14 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.99 | 1 |
| Exact Sciences Corporation | $17.32 | 1 |
| INOGEN, INC. | $16.81 | 1 |
| Amgen Inc. | $14.50 | 1 |
| GlaxoSmithKline, LLC. | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.39 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084979 | CMS |
| ABBVIE INC. | $0.22 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084981 | CMS |
| ABBVIE INC. | $0.39 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084983 | CMS |
| ABBVIE INC. | $18.17 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084985 | CMS |
| ABBVIE INC. | $17.14 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084987 | CMS |
| ABBVIE INC. | $27.59 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084989 | CMS |
| ABBVIE INC. | $26.16 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084991 | CMS |
| ABBVIE INC. | $19.33 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084993 | CMS |
| ABBVIE INC. | $22.12 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084995 | CMS |
| ABBVIE INC. | $21.11 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084997 | CMS |
| ABBVIE INC. | $1.81 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105084999 | CMS |
| ABBVIE INC. | $10.18 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085001 | CMS |
| Amgen Inc. | $14.50 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117335206 | CMS |
| Astellas Pharma US Inc | $18.12 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139274918 | CMS |
| Astellas Pharma US Inc | $17.02 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139280234 | CMS |
| Exact Sciences Corporation | $17.32 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114538445 | CMS |
| GlaxoSmithKline, LLC. | $13.72 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116603025 | CMS |
| INOGEN, INC. | $16.81 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144988769 | CMS |
| Lilly USA, LLC | $15.24 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106479 | CMS |
| Lilly USA, LLC | $17.94 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135131448 | CMS |
| Lilly USA, LLC | $17.00 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135130438 | CMS |
| Lundbeck LLC | $28.80 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145949012 | CMS |
| Lundbeck LLC | $18.75 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145949014 | CMS |
| Novartis Pharmaceuticals Corporation | $24.99 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086995996 | CMS |
| Novo Nordisk Inc | $18.34 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097209351 | CMS |
| Novo Nordisk Inc | $13.81 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096743988 | CMS |
| Novo Nordisk Inc | $15.93 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096973899 | CMS |
| Novo Nordisk Inc | $17.11 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096601199 | CMS |
| Novo Nordisk Inc | $16.29 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096974434 | CMS |
| Novo Nordisk Inc | $25.63 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096978071 | CMS |
| PFIZER INC. | $15.61 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130962985 | CMS |
| PFIZER INC. | $81.85 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131024788 | CMS |
| PFIZER INC. | $13.17 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131362437 | CMS |
| PFIZER INC. | $16.04 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131886707 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.03 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151099665 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.75 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151099667 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.